Advertisement
Screener

GENZYME CORP Patents: Applications Pending, 2024

GENZYME CORP Patent Applications Pending

108 applications still open at the USPTO, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2024-12-24: Application 63738721; Invention AAV GENOMES ENCODING ENGINEERED HUMAN FRATAXIN TRANSGENE; Applicant Genzyme Corporation; Status Provisional Application Expired.
  • 2024-12-23: Application PCTUS2024061704; Invention FLUID TRANSFER DEVICE; Applicant GENZYME CORPORATION; Status RO PROCESSING COMPLETED-PLACED IN STORAGE.
  • 2024-12-23: Application 18991856; Invention RABBIT ANTIBODIES TO HUMAN IMMUNOGLOBULINS G; Applicant Genzyme Corporation; Status Docketed New Case - Ready for Examination.
  • 2024-12-20: Application 18877756; Invention SOLID FORMS OF DEUTERATED COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS; Applicant GENZYME CORPORATION; Status Sent to Classification contractor.
FiledApplicationInventionApplicantStatusPublished asInventor nameInventor countryExaminer
2024-12-2463738721AAV GENOMES ENCODING ENGINEERED HUMAN FRATAXIN TRANSGENEGenzyme CorporationProvisional Application Expired
Daniel Marc DUBREUIL
Michael Fleming
Shyam Ramachandran
United States
United States
United States
2024-12-23PCTUS2024061704FLUID TRANSFER DEVICEGENZYME CORPORATIONRO PROCESSING COMPLETED-PLACED IN STORAGE
HAIMING WU
DANIAL FERREIRA
United States
United States
2024-12-2318991856RABBIT ANTIBODIES TO HUMAN IMMUNOGLOBULINS GGenzyme CorporationDocketed New Case - Ready for ExaminationUS20250237662A1
Ruiyin CHU
United States
CENTRAL, DOCKET
2024-12-2018877756SOLID FORMS OF DEUTERATED COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORSGENZYME CORPORATIONSent to Classification contractor
Pierre DEMONTIGNY
Craig S. SIEGEL
Donglai YANG
United States
United States
United States
2024-12-19PCTUS2024060932CRYSTALLINE FORM OF AN ISOXAZOLIDINE DERIVATIVEGENZYME CORPORATIONRO PROCESSING COMPLETED-PLACED IN STORAGE
NATASCHA ENGEL
HELENA MORA RADÓ
Germany
Germany
2024-12-1918988366BIOMARKERS OF METHOTREXATE-INDUCED IMMUNE TOLERANCEGenzyme CorporationDocketed New Case - Ready for ExaminationUS20250120976A1
Alexandra Joseph
Johnson Tran
Susan M. Richards
United States
United States
United States
CENTRAL, DOCKET
2024-12-17PCTUS2024060580IL-12 LOSS OF POTENCY MUTEINSGENZYME CORPORATIONRO PROCESSING COMPLETED-PLACED IN STORAGE
CLAIRE LHUILLIER
CHRISTIAN BEIL
JOSÉ ANTONIO AMENGUAL RIGO
YU QIU
XIANGMING LI
United States
United States
United States
United States
United States
2024-12-1363733966TREATMENT OF HEMOPHILIA WITH FITUSIRAN IN PEDIATRIC PATIENTSGenzyme CorporationProvisional Application Expired
Malidi Ahamadi
Shauna Andersson
Timothy Chow
Barbara Kittner
Fadi Shammas
United States
United States
United States
United States
Canada
2024-12-12PCTUS2024059764ARTIFICIAL MICRORNAS TARGETING TAUGENZYME CORPORATIONRO PROCESSING COMPLETED-PLACED IN STORAGE
BRADFORD MILLER ELMER
JESSICA MARIE HOGESTYN
BRENDA RICHARDS
SHYAM RAMACHANDRAN
United States
United States
United States
United States
2024-12-1218978680ARTIFICIAL microRNAs TARGETING TAUGenzyme CorporationDocketed New Case - Ready for ExaminationUS20250197862A1
Bradford Miller ELMER
Jessica Marie HOGESTYN
Shyam RAMACHANDRAN
Brenda RICHARDS
United States
United States
United States
United States
CENTRAL, DOCKET
2024-12-1118976471Multivariate Spectral Analysis and Monitoring for BiomanufacturingGenzyme CorporationDocketed New Case - Ready for ExaminationUS20250246268A1
Dhanuka Pulasthi Wasalathanthri
Jagdish C. Tewari
Xuezhen Kang
Marina Hincapie
Shawn L. Barrett
Julie Susanne Pollock
United States
United States
United States
United States
United States
United States
CENTRAL, DOCKET
2024-12-0518872107FITUSIRAN FOR THE TREATMENT OF HEMOPHILIA A AND B IN PEDIATRIC PATIENTSGenzyme CorporationDocketed New Case - Ready for ExaminationUS20260240891A1
Shauna ANDERSSON
Pratik R BHAGUNDE
Sajida IQBAL
Pranav PATEL
Stacey POLOSKEY
Fadi SHAMMAS
United States
United States
United Kingdom
United States
United States
Canada
CENTRAL, DOCKET
2024-11-27PCTUS2024057831IMAGE-BASED MOTOR FUNCTION ASSESSMENTGENZYME CORPORATIONRO PROCESSING COMPLETED-PLACED IN STORAGE
HILLOL SARKER
ELENA GARGAUN
QI TANG
United States
United States
United States
2024-11-26PCTUS2024057416METHODS FOR TREATING DIGITALLY-IDENTIFIED CD20-RELATED DISORDERSGENZYME CORPORATIONRO PROCESSING COMPLETED-PLACED IN STORAGE
CLIONA MARIE MOLONY
United States
2024-11-2618960796METHODS FOR TREATING DIGITALLY-IDENTIFIED CD20-RELATED DISORDERSGenzyme CorporationDocketed New Case - Ready for ExaminationUS20250179207A1
Cliona Marie Molony
United States
CENTRAL, DOCKET
2024-11-2618960725VISUAL AID FOR ASSISTING A USER IN THE PREPARATION OF A PLURALITY OF SYRINGESGenzyme CorporationResponse to Non-Final Office Action Entered and Forwarded to ExaminerUS20260144708A1
Martin Michael Coyne III
Madeleine Hayden Anderson
Katherine Ford Brigham
Alejandra Linares Martinez
Matthew Conner D'Auria
United States
United States
United States
United States
United States
HU, KANG
2024-11-2563724836IONIZABLE CATIONIC LIPIDS AND LIPID NANOPARTICLES, AND METHODS OF SYNTHESIS AND USE THEREOFGenzyme CorporationProvisional Application Expired
Zhaohua Richard HUANG
Feng LIANG
Hong WANG
United States
United States
United States
2024-11-2518958540VIAL ADAPTER AND INJECTION KIT FOR WITHDRAWING A LIQUID MEDICAMENT FROM AN INJECTION VIALGenzyme CorporationPublications -- Issue Fee Payment ReceivedUS20260144709A1
Haiming Wu
Danial Ferreira
United States
United States
MARCETICH, ADAM M
2024-11-2118867941METHODS FOR IDENTIFYING AND TREATING DISEASESGenzyme CorporationDocketed New Case - Ready for ExaminationUS20250264484A1
Can Kayatekin
Jennifer Clarke Matthews
Sergio Pablo Sardi
United States
United States
United States
CURRENS, GRANT CARSON
2024-11-20PCTUS2024056683FLUID TRANSFER DEVICEGENZYME CORPORATIONRO PROCESSING COMPLETED-PLACED IN STORAGE
DANIAL FERREIRA
HAIMING WU
United States
United States
2024-11-15PCTUS2024056213METHODS OF TREATING GAUCHER DISEASE AND GBA-PARKINSON'S DISEASEGENZYME CORPORATIONRO PROCESSING COMPLETED-PLACED IN STORAGE
SWATHI AYLOO
SHYAM RAMACHANDRAN
United States
United States
2024-11-15PCTUS2024056209METHODS OF TREATING NEURODEGENERATIVE DISORDERSGENZYME CORPORATIONRO PROCESSING COMPLETED-PLACED IN STORAGE
SHYAM RAMACHANDRAN
United States
2024-11-1518949549METHODS OF TREATING GAUCHER DISEASE AND GBA-PARKINSON’S DISEASEGenzyme CorporationDocketed New Case - Ready for ExaminationUS20250152747A1
Swathi AYLOO
Shyam RAMACHANDRAN
United States
United States
JACKSON III, WALTER
2024-11-1518949540METHODS OF TREATING NEURODEGENERATIVE DISORDERSGenzyme CorporationNon Final Action MailedUS20250152744A1
Shyam RAMACHANDRAN
United States
GU, QINHUA
2024-11-1218944437HUMAN PAH EXPRESSION CASSETTE FOR TREATMENT OF PKU BY LIVER-DIRECTED GENE REPLACEMENT THERAPYGENZYME CORPORATIONDocketed New Case - Ready for ExaminationUS20250179522A1
Sirkka R.M. KYOSTIO-MOORE
United States
CENTRAL, DOCKET
2024-11-0618939307MODIFIED-IgG ANTIBODIES THAT BIND TRANSFORMING GROWTH FACTOR-BETA1 WITH HIGH AFFINITY, AVIDITY AND SPECIFICITYGenzyme CorporationDocketed New Case - Ready for ExaminationUS20250179163A1
Huawei QIU
Julie BIRD
United States
United States
CENTRAL, DOCKET
2024-11-0163715188LIPID NANOPARTICLES TARGETING CENTRAL NERVOUS SYSTEM ENDOTHELIAL CELLSGenzyme CorporationProvisional Application Expired
Amey Bandekar
Martin Goulet
Michael Scott Fleming
Paria Moxley
United States
United States
United States
United States
2024-10-2918930067SYSTEMS AND DEVICES FOR PRODUCING BIOLOGICAL PRODUCTS AND METHODS OF USING THE SAMEGenzyme CorporationDocketed New Case - Ready for ExaminationUS20250051705A1
Kevin Brower
Michael Coolbaugh
Xhorxhi Gjoka
Chad Varner
Jason Walther
United States
United States
United States
United States
United States
CENTRAL, DOCKET
2024-10-2563711808HOST CELL LINE ENGINEERING TO IMPROVE RAAV PRODUCTIONGENZYME CORPORATIONProvisional Application Expired
Huimin Na
Yingchao Nie
United States
United States
2024-10-2263710457PROCESS FOR INSERTING TARGETING LIGAND INTO A LIPID NANOPARTICLE ENCAPSULATING NUCLEIC ACID AND COMPOSITIONS PRODUCED THEREFROMGenzyme CorporationProvisional Application Expired
Amey Bandekar
Isidro Zarraga
United States
United States
2024-10-1863709161TREATMENT OF HEMOPHILIA WITH FITUSIRANGenzyme CorporationProvisional Application Expired
Marion Afonso
Marek Demissie
Yingwen Dong
Lila-Sabrina Fetita
Barbara Kittner
Joshua Maher
Laurel Menapace
Jerome Msihid
Marja Puurunen
Yuqian Shen
Julia Xiong
Chuanwu Zhang
France
United States
United States
France
United States
United Kingdom
United States
France
United States
United States
United States
United States
2024-10-1663708209RAAV PRODUCTION AND PARTICLE QUALITY BY MODULATING CULTURE LEVELS OF CARBON DIOXIDEGenzyme CorporationProvisional Application Expired
Bruno Figueroa
Nipun Goel
Madhuresh Sumit
United States
United States
United States
2024-10-1663708132Process For Preparing (S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydropyrido[3,2-b][1,4]oxazepin-3-yl)-4H-1,2,4-triazole-3-carboxamideGenzyme CorporationProvisional Application Expired
Raphaël Beltran
Xavier Bon
Brenda Burke
Colton Davis
Antoine De Gombert
Austin Kelly
Naoko Ichiishi
France
France
United States
United States
France
United States
United States
2024-10-1563707647PROCESS FOR PREPARING (S)-5-BENZYL-N-(5-METHYL-4-OXO-2,3,4,5-TETRAHYDROPYRIDO[3,2-B][1,4]OXAZEPIN-3-YL)-4H-1,2,4-TRIAZOLE-3-CARBOXAMIDEGenzyme CorporationProvisional Application Expired
Raphaêl Beltran
Xavier Bon
Brenda Burke
Colton Davis
Antoine De Gombert
Austin Kelly
Naoko Ichiishi
France
France
United States
United States
France
United States
United States
2024-10-03PCTUS2024049741PREDICTING PHARMACOKINETIC PROFILES OF CHEMICAL COMPOUNDS USING MACHINE LEARNINGGENZYME CORPORATIONRO PROCESSING COMPLETED-PLACED IN STORAGE
ALEXANDRA ABOS ORTEGA
PANTELEIMON D. MAVROUDIS
NIKHIL S. PILLAI
United States
United States
United States
2024-09-2718900128ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOFGENZYME CORPORATIONDocketed New Case - Ready for ExaminationUS20250122186A1
Elisabeth DEFOSSA
Uwe HEINELT
Hans MATTER
Maria MENDEZ-PEREZ
Nils RACKELMANN
Kurt RITTER
Hauke SZILLAT
Gernot ZECH
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
HABTE, KAHSAY
2024-09-2618897864OLIGOSACCHARIDES COMPRISING AN AMINOOXY GROUP AND CONJUGATES THEREOFGenzyme CorporationDocketed New Case - Ready for ExaminationUS20250263685A1
Yunxiang ZHU
Seng CHENG
Canwen JIANG
Luis Z. AVILA
United States
United States
United States
United States
CENTRAL, DOCKET
2024-09-2518895975Process For Preparing SHP2 InhibitorsGenzyme CorporationNotice of Allowance Mailed -- Application Received in Office of PublicationsUS20250034160A1
Fabio Morana
Davide Gornati
Jacopo Roletto
Italy
Italy
Italy
OTTON, ALICIA L
2024-09-2463698530IONIZABLE CATIONIC LIPIDS AND LIPID NANOPARTICLES, AND METHODS OF SYNTHESIS AND USE THEREOFGenzyme CorporationProvisional Application Expired
Zhaohua Richard HUANG
Feng LIANG
Hong WANG
United States
United States
United States
2024-09-2063697392METHODS AND COMPOSITIONS FOR RAAV PRODUCTIONGenzyme CorporationProvisional Application Expired
Rachel Martineau
Ying Liu
United States
United States
2024-09-1863696324Production of Recombinant AAVGenzyme CorporationProvisional Application Expired
Meghana Kodalali Basavaraj
Jarrod Dean
Prasad Kesanakurti
Christian Mueller
Catherine O’Riordan
United States
United States
United States
United States
United States
2024-09-16PCTUS2024046873TREATMENT OF HEMOPHILIA A WITH FITUSIRANGENZYME CORPORATIONRO PROCESSING COMPLETED-PLACED IN STORAGE
SHAUNA ANDERSSON
VIRIDIANA CANO
EKTA SETH CHHABRA
SAJIDA IQBAL
BARBARA KITTNER
LAUREL MENAPACE
SALIM KICHOU
United States
United States
United States
United Kingdom
United States
United States
France
2024-09-1363694636AAV-MEDIATED OCULAR GENE THERAPYGenzyme CorporationProvisional Application Expired
Suzanne Jacobs
Catherine O’Riordan
Jennifer Sullivan
United States
United States
United States
2024-09-0418823894Perfusion Bioreactor With Filtration SystemsGenzyme CorporationNotice of Allowance Mailed -- Application Received in Office of PublicationsUS20250027031A1
Jiuyi Lu
Jason Walther
Jonathan Wang
Kevin Victor Chen
United States
United States
United States
United States
DRODGE, JOSEPH W
2024-08-27PCTUS2024043947PYRAZOLYL COMPOUNDS AS EMOPAMIL BINDING PROTEIN INHIBITORSGENZYME CORPORATIONRO PROCESSING COMPLETED-PLACED IN STORAGE
JOHN ZIQI JIANG
SUNGTAEK LIM
GREGORY H. MERRIMAN
PAUL JUSTIN MUELLER
SUKANTHINI THURAIRATNAM
United States
United States
United States
United States
United States
2024-08-2718817164Integrated Continuous Manufacturing of Therapeutic Protein Drug SubstancesGenzyme CorporationNon Final Action MailedUS20240417427A1
Konstantin Konstantinov
Rahul Godawat
Veena Warikoo
Sujit Jain
United States
United States
United States
United States
TSAY, MARSHA M
2024-08-1318802674Bone-Targeting AntibodiesGenzyme CorporationDocketed New Case - Ready for ExaminationUS20250074975A1
Huawei Qiu
Sunghae Park
James Stefano
United States
United States
United States
CENTRAL, DOCKET
2024-08-1263682073METHODS AND COMPOSITIONS FOR RAAV PRODUCTIONGenzyme CorporationProvisional Application Expired
Rachel E. Martineau
Ying Liu
United States
United States
2024-08-1218801293METHODS FOR DETECTING AAVGenzyme CorporationDocketed New Case - Ready for ExaminationUS20250027951A1
Xiaoying JIN
Catherine O'Riordan
Lin Liu
Kate Zhang
United States
United States
United States
United States
CENTRAL, DOCKET
2024-08-0718797302ANALYTICAL ULTRACENTRIFUGATION FOR CHARACTERIZATION OF RECOMBINANT VIRAL PARTICLESGenzyme CorporationDocketed New Case - Ready for ExaminationUS20240393222A1
Catherine R. O'RIORDAN
Brenda BURNHAM
United States
United States
GILL, RACHEL B
2024-08-0563679419TREATMENT OF HEMOPHILIA WITH FITUSIRANGenzyme CorporationProvisional Application Expired
Marion AFONSO
Marek DEMISSIE
Yingwen DONG
Lila-Sabrina FETITA
Barbara KITTNER
Joshua MAHER
Laurel MENAPACE
Jerome MSIHID
Marja Puurunen
Yuqian SHEN
Julia XIONG
Chuanwu ZHANG
France
United States
United States
France
United States
United Kingdom
United States
France
United States
United States
United States
United States
2024-08-0118792190Methods of Controlling the Formation of Disulfide Bonds in Protein SolutionsGENZYME CORPORATIONDocketed New Case - Ready for ExaminationUS20240392030A1
Kevin P. BROWER
Chris HWANG
Rao KODURI
Konstantin B. KONSTANTINOV
Veena WARIKOO
Jin YIN
Marcella YU
United States
United States
United States
United States
United States
United States
United States
CENTRAL, DOCKET
2024-07-3163678006TREATMENT OF HEMOPHILIA WITH FITUSIRANGenzyme CorporationProvisional Application Expired
Marion AFONSO
Marek DEMISSIE
Yingwen DONG
Lila-Sabrina FETITA
Barbara KITTNER
Joshua MAHER
Laurel MENAPACE
Jerome MSIHID
Marja Puurunen
Yuqian SHEN
Julia XIONG
Chuanwu ZHANG
France
United States
United States
France
United States
United Kingdom
United States
France
United States
United States
United States
United States
2024-07-2918787702SITE-SPECIFIC ANTIBODY-DRUG CONJUGATION THROUGH GLYCOENGINEERINGGenzyme CorporationDocketed New Case - Ready for ExaminationUS20250066497A1
Clark Pan
Qun Zhou
James Stefano
Pradeep Dhal
Bo Chen
Diego Gianolio
Robert Miller
Huawei Qiu
United States
United States
United States
United States
United States
United States
United States
United States
CENTRAL, DOCKET
2024-07-2663675981PREDICTING PHARMACOKINETIC PROFILES OF CHEMICAL COMPOUNDS USING MACHINE LEARNINGGenzyme CorporationProvisional Application Expired
Alexandra Abos Ortega
Panteleimon D. Mavroudis
Nikhil S. Pillai
Spain
United States
United States
2024-07-2563675530METHOD FOR SELECTIVELY CONTROLLING THE GENERATION OF DEGRADANTS FROM A BIOLOGICAL PRODUCT EXPOSED TO A STRESS CONDITIONGENZYME CORPORATIONProvisional Application Expired
Dennis Adrian DELGADO
United States
2024-07-1918777773GLUCOSYLCERAMIDE SYNTHASE INHIBITORSGenzyme CorporationResponse to Non-Final Office Action Entered and Forwarded to ExaminerUS20250026749A1
Elyse BOURQUE
Mario A. CABRERA-SALAZAR
Cassandra CELATKA
Seng H. CHENG
Bradford HIRTH
Andrew GOOD
Katherine JANCSICS
John MARSHALL
Markus METZ
Ronald K. SCHEULE
Renato SKERLJ
Yibin XIANG
Zhong ZHAO
John LEONARD
Thomas NATOLI
Elina MAKINO
Herve HUSSON
Oxana BESKROVNAYA
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
MCDOWELL, BRIAN E
2024-07-1118770474TREATMENT OF CANCER WITH ANTI-ILT2 ANTIBODIESGENZYME CORPORATION
BIOND BIOLOGICS LTD.
Docketed New Case - Ready for ExaminationUS20250019441A1
Dana Haves Ziv
Liat Tevel
Enas Halumi
Nyra Goldstein
Tsuri Peretz
Ilana Goldshtein
Tal Gabay
Anna Fridam-Dror
Itay Friedman
Sharon Hashmueli
Motti Hakim
Ilana Mandel
Avidor Shulman
Yair Sapir
Tehila Ben-Moshe
Giovanni Abbadessa
Meijing Wu
Nigel Patrick Somerville Crawford
Rui Wang
Maria Agarwal
Cecilia Deantonio
Raymond Perez
Ji Lin
Israel
Israel
Israel
Israel
Israel
Israel
Israel
Israel
Israel
Israel
Israel
Israel
Israel
Israel
Israel
United States
United States
United States
United States
United States
United Kingdom
United States
United States
CENTRAL, DOCKET
2024-07-0163666472PERFUSION IN PRODUCTION BIOREACTORGenzyme CorporationProvisional Application Expired
David R. Diaz Vera
Yelena Ilin
Adam E. Osborne
United States
United States
United States
2024-06-2763664881METHODS FOR TREATING RECEPTOR-INTERACTING PROTEIN KINASE 1-MEDIATED DISEASESGenzyme CorporationProvisional Application Expired
Christine FARENC
Donato TEUTONICO
Sabine SCHNYDER
France
France
United States
2024-06-26PCTUS2024035577PROCESS FOR PREPARING 4-(3,3-DIFLUORO-2,2-DIMETHYL-PROPANOYL)-3,5-DIHYDRO-2H-PYRIDO[3,4-F][1,4]OXAZEPINE-9-CARBONITRILEGENZYME CORPORATIONRO PROCESSING COMPLETED-PLACED IN STORAGE
JEAN-PIERRE LESZCZAK
United States
2024-06-2463663290METHODS FOR TREATING GAUCHER DISEASEGenzyme CorporationProvisional Application Expired
Isabela A. Batsu
Julie Kissell
Binfeng Xia
Christine Xu
United States
United States
United States
United States
2024-06-2163663043TREATMENT OF HEMOPHILIA WITH FITUSIRANGenzyme CorporationProvisional Application Expired
Marion AFONSO
Marek DEMISSIE
Yingwen DONG
Lila-Sabrina FETITA
Barbara KITTNER
Joshua MAHER
Laurel MENAPACE
Jerome MSIHID
Marja Puurunen
Yuqian SHEN
Julia XIONG
Chuanwu ZHANG
France
United States
United States
France
United States
United Kingdom
United States
France
United States
United States
United States
United States
2024-06-2118723352Fitusiran for Use in Improving Patient-Reported Outcome in Hemophilia PatientsGenzyme CorporationDocketed New Case - Ready for ExaminationUS20250064842A1
Shauna Andersson
Jose Bartelt-Hofer
Pronabesh Dasmahapatra
United States
France
United States
MCINTOSH III, TRAVISS C
2024-06-1463659914Neural Network System for Predicting and Localizing Skin ConditionsGenzyme CorporationProvisional Application Expired
Ohn CHOW
Jimena DIAZ DE LEON CEVALLOS
Etienne POCHET
Bozhao QI
Qi TANG
Roger TRULLO
Jinlin XIANG
Yongjian YANG
Ruisu ZHANG
Wei ZHAO
United States
Mexico
France
United States
United States
France
United States
United States
United States
United States
2024-06-1218741190INHIBITORS OF T-CELL ACTIVATIONGENZYME CORPORATIONDocketed New Case - Ready for ExaminationUS20250002578A1
Yunxiang Zhu
Jozsef Karman
Ronnie Wei
Canwen Jiang
Seng Cheng
United States
United States
United States
United States
United States
CENTRAL, DOCKET
2024-06-0563656433BINDING PROTEINS THAT TARGET aC1s, TfR, OR BOTH, AND COMPOSITIONS THEREOFGenzyme CorporationProvisional Application Expired
Cécile Capdevila
Blandine Duperrier
Timothy Hammond
Ayman Ismail
Sagar Kathuria
Nina Leksa
Alessandro Masiero
Sunghae Park
Yu Qiu
Anke Steinmetz
Serhan Zenger
France
France
United States
United States
United States
United States
France
United States
United States
Germany
United States
2024-05-28PCTUS2024031274SLEEP-WAKE CLASSIFICATION USING MACHINE LEARNINGGENZYME CORPORATIONRO PROCESSING COMPLETED-PLACED IN STORAGE
MIKEL MARTINEZ IPARRAGUIRRE
HANEEN NJOUM
HILLOL SARKER
ELIAS ABOU ZEID
United States
United States
United States
United States
2024-05-2418674045DRUG DELIVERY DEVICE FOR DELIVERING AT LEAST ONE DRUG, OPTIONALLY AT LEAST ONE RECONSTITUTED DRUG, MEDICAL DEVICE AND MEDICAL SYSTEMGENZYME CORPORATIONNotice of Allowance Mailed -- Application Received in Office of PublicationsUS20250360263A1
Alexander Hee-Hanson
Thomas Lever
Craig Harvey Nelson
Haiming Wu
United Kingdom
United Kingdom
United Kingdom
United States
TURKOWSKI, KAYLA MARIE
2024-05-22PCTUS2024030593TREATMENT OF MULTIPLE SCLEROSIS WITH ANTI-CD40L ANTIBODIESGENZYME CORPORATIONRO PROCESSING COMPLETED-PLACED IN STORAGE
CHRISTINE FARENC
PHILIPPE TRUFFINET
FABIENNE SCHUMACHER
United States
United States
United States
2024-05-2218671636TREATMENT OF MULTIPLE SCLEROSIS WITH ANTI-CD40L ANTIBODIESGenzyme CorporationNon Final Action MailedUS20240392022A1
Christine FARENC
Philippe TRUFFINET
Fabienne SCHUMACHER
France
France
Germany
PETERS, ALEC JON
2024-05-10PCTUS2024028764PREDICTING MOTOR FUNCTION SCORES IN POMPE DISEASE TREATMENTGENZYME CORPORATIONRO PROCESSING COMPLETED-PLACED IN STORAGE
JULIE L. BATISTA
KELLY GEORGE
KRISTINA AN HAACK
RANA JREICH
CHANCHALA KADDI
ZHAOLING MENG
CATHERINE ORTEMANN-RENON
FATIHA RACHEDI
MENGDI TAO
ATEF ZAHER
SUSANA ZAPH
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
2024-05-0918659600DRUG FORMULATIONS OF 4-(3,3-DIFLUORO-2,2-DIMETHYL-PROPANOYL) -3,5-DIHYDRO-2H-PYRIDO[3,4-f][1,4]OXAZEPINE-9-CARBONITRILEGenzyme CorporationNon Final Action MailedUS20240299412A1
Jerome Arigon
Marilyn Calderone
Brigitte Illel
France
France
France
HOWELL, THEODORE R
2024-05-0863644233Profiling of Biodistribution of Barcoded Libraries of AAV CapsidsGenzyme CorporationProvisional Application Expired
Sourav Roy Choudhury
Margaret Hennessy
Eugenia Lyashenko
Rachna Manek
United States
United States
United States
United States
2024-05-07PCTUS2024028164ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOFGENZYME CORPORATIONRO PROCESSING COMPLETED-PLACED IN STORAGE
ELISABETH DEFOSSA
NIELS GRIESANG
UWE HEINELT
HANS MATTER
MARIA MENDEZ-PEREZ
NILS RACKELMANN
LOTHAR SCHWINK
Germany
Germany
Germany
Germany
Germany
Germany
Germany
2024-05-07PCTUS2024028154ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOFGENZYME CORPORATIONRO PROCESSING COMPLETED-PLACED IN STORAGE
ELISABETH DEFOSSA
NIELS GRIESANG
UWE HEINELT
HANS MATTER
MARIA MENDEZ-PEREZ
NILS RACKELMANN
LOTHAR SCHWINK
Germany
Germany
Germany
Germany
Germany
Germany
Germany
2024-05-07PCTUS2024028142ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOFGENZYME CORPORATIONRO PROCESSING COMPLETED-PLACED IN STORAGE
ELISABETH DEFOSSA
NILS RACKELMANN
UWE HEINELT
HANS MATTER
MARIA MENDEZ-PEREZ
KURT RITTER
HAUKE SZILLAT
GERNOT ZECH
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
2024-05-0663643156TREATMENT OF CANCER WITH ANTI-ILT2 ANTIBODIESGENZYME CORPORATION
BIOND BIOLOGICS LTD.
Provisional Application Expired
Dana Haves Ziv
Liat Tevel
Enas Halumi
Nyra Goldstein
Tsuri Peretz
Ilana Goldshtein
Tal Gabay
Anna Fridam-Dror
Itay Friedman
Sharon Hashmueli
Motti Hakim
Ilana Mandel
Avidor Shulman
Yair Sapir
Tehila Ben-Moshe
Giovanni Abbadessa
Meijing Wu
Nigel Patrick Somerville Crawford
Rui Wang
Maria Agarwal
Cecilia Deantonio
Raymond Perez
Ji Lin
Israel
Israel
Israel
Israel
Israel
Israel
Israel
Israel
Israel
Israel
Israel
Israel
Israel
Israel
Israel
United States
United States
United States
United States
United Kingdom
United States
United States
2024-05-03PCTUS2024027768PARKINSON'S TREMOR CLASSIFICATION USING MACHINE LEARNINGGENZYME CORPORATIONRO PROCESSING COMPLETED-PLACED IN STORAGE
HANEEN NJOUM
HILLOL SARKER
ELIAS ABOU ZEID
United States
United States
United States
2024-04-26PCTUS2024026555METHODS OF IMPROVING RAAV PRODUCTIONGENZYME CORPORATIONRO PROCESSING COMPLETED-PLACED IN STORAGE
SRINIVAS NELLIMARLA
KEVIN VICTOR CHEN
JEONG LEE
CARLOS BENITEZ
YING LIU
United States
United States
United States
United States
United States
2024-04-2618648199METHODS OF IMPROVING RAAV PRODUCTIONGenzyme CorporationNon Final Action MailedUS20240360423A1
Srinivas Nellimarla
Kevin Victor Chen
Jeong Lee
Carlos Benitez
Ying Liu
United States
United States
United States
United States
United States
VAN BUREN, LAUREN K
2024-04-2563638871ARTIFICIAL microRNAs TARGETING SNCAGenzyme CorporationProvisional Application Expired
Bradford Miller ELMER
Shyam Ramachandran
United States
United States
2024-04-2418644528HUMANIZED ANTI-COMPLEMENT FACTOR BB ANTIBODIES AND USES THEREOFGenzyme CorporationFinal Rejection MailedUS20240391986A1
Graham Parry
Stephen Moore
Michael J. Storek
Nina C. Leksa
United States
United States
United States
United States
MIDDLETON, DANAYA L
2024-04-1663634863PATIENT SELECTION BY PREDICTING TARGET GENE ESSENTIALITY USING MACHINE LEARNINGGenzyme CorporationProvisional Application Expired
Mi Yang
United States
2024-04-1663634568SALTS OF IRAK4 DEGRADERGenzyme CorporationProvisional Application Expired
Jean-Philippe Jelin
Olivier Monnier
Jérôme Roche
Fady Ibrahim
Corinne Barre
France
France
France
United States
France
2024-04-0863631193TREATMENT OF FACTOR X DEFICIENCY WITH FITUSIRANGenzyme CorporationProvisional Application Expired
Caterina Casari
Olivier Christophe
Cécile Denis
Petrus J. Lenting
Geneviève McCluskey
France
France
France
France
France
2024-04-0518628338FLUID GUIDE SYSTEM USABLE FOR DRUG HANDLING, EG. FOR RECONSTITUTION, CORRESPONDING MEDICAL DEVICE, METHOD AND COMPUTER RELATED ITEMSGENZYME CORPORATIONNotice of Allowance Mailed -- Application Received in Office of PublicationsUS20250312527A1
Craig Harvey Nelson
Alexander Hee-Hanson
Thomas Lever
Haiming Wu
United Kingdom
United Kingdom
United Kingdom
United States
SMALE, AVERY E
2024-04-04PCTUS2024022938TARGETED GENE THERAPY FOR DM-1 MYOTONIC DYSTROPHYGENZYME CORPORATIONRO PROCESSING COMPLETED-PLACED IN STORAGE
SENG CHENG
SARAH MELISSA JACOBO
TAKAKO MORIGUCHI
CATHERINE O'RIORDAN
GUOXIANG RUAN
United States
United States
United States
United States
United States
2024-04-0418626784TARGETED GENE THERAPY FOR DM-1 MYOTONIC DYSTROPHYGenzyme CorporationNon Final Action MailedUS20240384271A1
Seng Cheng
Sarah Melissa Jacobo
Takako Moriguchi
Catherine O'Riordan
Guoxiang Ruan
United States
United States
United States
United States
United States
BRETZ, COREY LANE
2024-04-03PCTUS2024022746DEVICES FOR CELL LYSIS AND METHODS OF USE THEREOFGENZYME CORPORATIONRO PROCESSING COMPLETED-PLACED IN STORAGE
ETHAN LOVDAL BUTLER
MARIO G. JABRA
JUNFEN MA
YUANLI SONG
United States
United States
United States
United States
2024-04-0163572854TREATMENT OF FACTOR X DEFICIENCY WITH FITUSIRANGenzyme CorporationProvisional Application Expired
Caterina CASARI
Olivier CHRISTOPHE
Cécile DENIS
Petrus J. Lenting
Geneviève McCLUSKEY
France
France
France
France
France
2024-03-2863571018POLYPEPTIDES BINDING TO A SPECIFIC EPITOPE OF THE TRANSFERRIN RECEPTOR 1GENZYME CORPORATIONProvisional Application Expired
Sigrid Cornelis
Nina Leksa-Gordon
Dominique Lesuisse
Kristof Moonens
Christelle Nonne
Chiara Rapisarda
Joeri T’Syen
Belgium
United States
France
Belgium
Belgium
France
Belgium
2024-03-15PCTUS2024020242TREATMENT OF DRY AGE-RELATED MACULAR DEGENERATIONGENZYME CORPORATIONRO PROCESSING COMPLETED-PLACED IN STORAGE
MATTHEW ADAMOWICZ
HAO CHEN
AMY FREDERICK
CHRISTIAN MUELLER
CATHERINE O'RIORDAN
VAISHNAVI RAJAGOPAL
JOHN C. REED
MICHAEL JOHN STOREK
United States
United States
United States
United States
United States
United States
United States
United States
2024-03-1518607056Treatment of Dry Age-Related Macular DegenerationGenzyme CorporationNon Final Action MailedUS20240401082A1
Matthew Adamowicz
Hao Chen
Amy Frederick
Christian Mueller
Catherine O’Riordan
Vaishnavi Rajagopal
John C. Reed
Michael John Storek
United States
United States
United States
United States
United States
United States
United States
United States
JACKSON III, WALTER
2024-03-0863563003LIPID NANOPARTICLESGenzyme CorporationProvisional Application Expired
Zhaohua Richard Huang
Sheryl Wang
United States
United States
2024-03-0418594597MEDICAMENT DELIVERY DEVICEGenzyme CorporationNon Final Action MailedUS20250276131A1
Alexander Hee-Hanson
Thomas Lever
Michael Parrott
Robert Wilson
United Kingdom
United Kingdom
United Kingdom
United Kingdom
OSINSKI, BRADLEY JAMES
2024-03-0118593686INDOLE COMPOUNDS AND METHODS OF USEGenzyme CorporationDocketed New Case - Ready for ExaminationUS20240279220A1
Junkai Liao
Mark Munson
Sukanthini Thurairatnam
Bradford Hirth
Zhongli Gao
Gregory Hurlbut
David Borcherding
Matthieu Barrague
Timothy Alan Gillespy
Alexandre Gross
Andrew Good
Roy Vaz
Jinyu Liu
Yi Li
Markus Metz
Anatoly Ruvinsky
Claude Barberis
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
ANDERSON, REBECCA L
2024-03-0118593643INDOLE COMPOUNDS AND METHODS OF USEGENZYME CORPORATIONNon Final Action MailedUS20240239784A1
Junkai Liao
Mark Munson
Sukanthini Thurairatnam
Bradford Hirth
Zhongli Gao
Gregory Hurlbut
David Borcherding
Matthieu Barrague
Timothy Alan Gillespy
Alexandre Gross
Thaddeus Nieduzak
Andrew Good
Roy Vaz
Jinyu Liu
Yi Li
Markus Metz
Anatoly Ruvinsky
Michael Kothe
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
HEASLEY, MEGHAN CHRISTINE
2024-02-09PCTUS2024015160AUTOMATED SCREENING FOR ACID SPHINGOMYELINASE DEFICIENCYGENZYME CORPORATIONRO PROCESSING COMPLETED-PLACED IN STORAGE
ALEXANDRA DUMITRIU
MAJA GASPARIC
PAULINE MARIE GUILMIN
MARTIN KRISTIAN LOUIS MONTMERLE
STEFAAN SANSEN
NEHA B. SHAH
United States
United States
France
France
Belgium
United States
2024-02-0963552026TREATMENT OF HEMOPHILIA WITH FITUSIRANGenzyme CorporationProvisional Application Expired
Marion AFONSO
Marek DEMISSIE
Yingwen DONG
Lila-Sabrina FETITA
Barbara KITTNER
Joshua MAHER
Laurel MENAPACE
Jerome MSIHID
Marja Puurunen
Yuqian SHEN
Julia XIONG
Chuanwu ZHANG
France
United States
United States
France
United States
United Kingdom
United States
France
United States
United States
United States
United States